Patient characteristics of 108 patients with chemosensitive disease (CR/PR) to ICE chemotherapy
Characteristic . | No. . | % . |
|---|---|---|
| Disease status | ||
| Relapsed | 71 | 66 |
| Primary refractory | 37 | 34 |
| Sex | ||
| Male | 70 | 65 |
| Female | 38 | 35 |
| Response to ICE | ||
| CR | 42 | 39 |
| PR | 66 | 61 |
| Age, y | ||
| Median | 46 | |
| Range | 18-68 | |
| Age stratified | ||
| Younger than 60 y | 89 | 82 |
| 60 y or older | 19 | 18 |
| KPS | ||
| 80% or more | 80 | 74 |
| Less than 80 | 28 | 26 |
| LDH | ||
| Normal | 53 | 49 |
| Less than normal | 55 | 51 |
| ENS | ||
| 1 site or less | 70 | 56 |
| More than 1 site | 38 | 35 |
| Stage | ||
| I/II | 28 | 26 |
| III/IV | 80 | 74 |
| Bone marrow | ||
| Uninvolved | 88 | 81 |
| Involved | 20 | 19 |
| sAAIPI | ||
| Low | 18 | 17 |
| Low-intermediate | 34 | 31 |
| High-intermediate | 39 | 36 |
| High | 17 | 16 |
Characteristic . | No. . | % . |
|---|---|---|
| Disease status | ||
| Relapsed | 71 | 66 |
| Primary refractory | 37 | 34 |
| Sex | ||
| Male | 70 | 65 |
| Female | 38 | 35 |
| Response to ICE | ||
| CR | 42 | 39 |
| PR | 66 | 61 |
| Age, y | ||
| Median | 46 | |
| Range | 18-68 | |
| Age stratified | ||
| Younger than 60 y | 89 | 82 |
| 60 y or older | 19 | 18 |
| KPS | ||
| 80% or more | 80 | 74 |
| Less than 80 | 28 | 26 |
| LDH | ||
| Normal | 53 | 49 |
| Less than normal | 55 | 51 |
| ENS | ||
| 1 site or less | 70 | 56 |
| More than 1 site | 38 | 35 |
| Stage | ||
| I/II | 28 | 26 |
| III/IV | 80 | 74 |
| Bone marrow | ||
| Uninvolved | 88 | 81 |
| Involved | 20 | 19 |
| sAAIPI | ||
| Low | 18 | 17 |
| Low-intermediate | 34 | 31 |
| High-intermediate | 39 | 36 |
| High | 17 | 16 |